Skip to main content
Premium Trial:

Request an Annual Quote

Rhone-Poulenc Recruits Head of Cochin Institute For New Science Post


PARIS--Rhone-Poulenc has named Axel Kahn its new deputy scientific director for health and agricultural biotechnology. He will be responsible for evaluating research proposals in medical and agricultural biotechnology throughout the Rhone-Poulenc organization. A medical geneticist, Kahn has been director of the Cochin Institute of Molecular Genetics here. He is also a member of the national bioethics commission of France, and served as chairman of the committee that advises the government on genetically modified organisms until resigning the position earlier this year after disagreeing with a government decision to ban the cultivation of transgenic maize.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.